You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • FRI0019 Clinical Responses by Baseline RA Disease Duration in the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naïve RA Patients with Background Methotrexate) Trial: 2-Year Results

Alerts

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - prognosis, predictors and outcome
FRI0019 Clinical Responses by Baseline RA Disease Duration in the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naïve RA Patients with Background Methotrexate) Trial: 2-Year Results
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address